| pubmed-article:20216409 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20216409 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20216409 | lifeskim:mentions | umls-concept:C0030567 | lld:lifeskim |
| pubmed-article:20216409 | lifeskim:mentions | umls-concept:C0023570 | lld:lifeskim |
| pubmed-article:20216409 | lifeskim:mentions | umls-concept:C0870071 | lld:lifeskim |
| pubmed-article:20216409 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:20216409 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:20216409 | pubmed:dateCreated | 2010-5-26 | lld:pubmed |
| pubmed-article:20216409 | pubmed:abstractText | The aims of the present study were to investigate the pharmacokinetic and pharmacodynamic (pk/pd) relationship of levodopa (l-dopa) in patients with advanced Parkinson disease (PD) and also to evaluate the effect of tolcapone on the pk/pd analysis of l-dopa in 1 patient with severe dyskinesias and fluctuations. | lld:pubmed |
| pubmed-article:20216409 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20216409 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20216409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20216409 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20216409 | pubmed:month | May | lld:pubmed |
| pubmed-article:20216409 | pubmed:issn | 1537-162X | lld:pubmed |
| pubmed-article:20216409 | pubmed:author | pubmed-author:SafranowKrzys... | lld:pubmed |
| pubmed-article:20216409 | pubmed:author | pubmed-author:BialeckaMonik... | lld:pubmed |
| pubmed-article:20216409 | pubmed:author | pubmed-author:Gawronska-Szk... | lld:pubmed |
| pubmed-article:20216409 | pubmed:author | pubmed-author:WyskaElzbieta... | lld:pubmed |
| pubmed-article:20216409 | pubmed:author | pubmed-author:Klodowska-Dud... | lld:pubmed |
| pubmed-article:20216409 | pubmed:author | pubmed-author:AdamiakUrszul... | lld:pubmed |
| pubmed-article:20216409 | pubmed:author | pubmed-author:KaldonskaMari... | lld:pubmed |
| pubmed-article:20216409 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20216409 | pubmed:volume | 33 | lld:pubmed |
| pubmed-article:20216409 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20216409 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20216409 | pubmed:pagination | 135-41 | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:meshHeading | pubmed-meshheading:20216409... | lld:pubmed |
| pubmed-article:20216409 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20216409 | pubmed:articleTitle | Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease. | lld:pubmed |
| pubmed-article:20216409 | pubmed:affiliation | Departments of Pharmacokinetics and Therapeutic Drug Monitoring, Pomeranian Medical University, Szczecin, Poland. | lld:pubmed |
| pubmed-article:20216409 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20216409 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:20216409 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
